Overview

Safety and Tolerability of Risperidone Implants

Status:
Completed

Trial end date:
2017-09-01

Target enrollment:

Participant gender:

Summary

A one year, open-label, study to evaluate the safety and tolerability of risperidone implants as a maintenance treatment in patients with schizophrenia

Phase:

Phase 3

Details

Lead Sponsor:

Braeburn Pharmaceuticals

Treatments:

Risperidone